8-K
Current Report
Vistagen Therapeutics, Inc. Filed Acc 0001415889-11-001342
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading form8k-11302011_101121.htm…